Drug Treatments T2D Flashcards
Sulfonylureas
- properties
- examples
- side effects
-all bound to plasma proteins so longer half life
-all orally active
E.g. glipizide, gliclazide
Major Side Effect:
-Hypoglycaemia
Sulfonylureas
-MOA
primary + secondary
stimulates endogenous insulin release
-binds to ATP sensitive K channel to promote insulin secretion
secondary
- Sensitize ß-cells to glucose
- Decrease lipolysis
- Decrease clearance of insulin by the liver
Biguanide drugs
-MOA
1) Increase glucose uptake in muscle
- increased GLUT4 translocation through AMPK
increases insulin sensitivity
2) Decrease glucose production by liver through AMPK and gene expression
Thiazolidinediones
Example
MOA
side effects:
E.G Pioglitazone
can reduce the effectiveness of OCP
This is the only one that is approved
Activate peroxisome proliferator-activated receptor-g (PPARg)
increases insulin sensitivity
adverse effects: weight gain, fluid retention, subject to interactions due to liver metabolism
Glucagon-like peptide-1 analogs
Give Example
sc injection
facilitates glucose control
promotes satiety
augments pancreas response
E.g. Exenatide
DPP IV inhibitors
- vildagliptin (reversible)
- sitagliptin (reversible)
- saxagliptin (covalently bound)
e. g.
- vildagliptin (reversible)
- sitagliptin (reversible)
- saxagliptin (covalently bound)
oral hypoglycaemic agents
increased levels of incretins GLP-1 and GIP
cancer risk
SGLT 2
High capacity
Low affinity
inhibit glucose transporter in small intestine and proximal straight tubule(90% glucose absorption occurs here)
Dapagliflozin
Canagliflozin
SGLT 1
Low capacity
High affinity
found in proximal convulated tubule
Effects of SGLT2 Inhibitors
- Increased insulin sensitivity in muscle
- increased insulin sensitivity in liver
- improved beta cell function
- decreased gluconeogenesis
side effects- weight loss, dehydration, can worsen UTI and thrush
Insulin
-Hepatic effects
Increases glycogenesis
Inhibits
- gluconeogenesis
- glycogenolysis
- ketogenesis
Insulin
-Skeletal muscle effects
increases GLUT 4 translocation=more glucose uptake
increases glucose oxidation, glycogenesis, amino acid uptake, protein synthesis
Decreases:
Glycogenolysis
amino acid release
Therapeutic uses
of sulfonylureas
best patient is
over 40 yrs. old
DM duration less than 10 yrs.
daily insulin (if taking) less than 40 units
Properties of metformin
- orally active
- does not bind to plasma protein
- excreted unchanged in urine
- also used for PCOS
Glitazones (thiazolidinediones)
Activate peroxisome proliferator-activated receptor-g (PPARg)
PPARs involved in transcription of insulin-responsive genes and in regulation of adipocyte lipid metabolism
orally active
4 causes of hyperglycaemia
Insulin resistance
B cell dysfunction
Loss of B cell mass
SGLT2 Inhibitors